IP Library Granted Patent US 9,745,603
Granted Patent B2
US 9,745,603 · App. 15/192,290 · Granted Aug 29, 2017

Biological production of multi-carbon compounds from methane

Inventors: William J. Coleman (Redwood City, CA); Genevieve M. Vidanes (San Francisco, CA); Guillaume Cottarel (Mountain View, CA); Sheela Muley (Fremont, CA); Roy Kamimura (Daly City, CA); Akbar F. Javan (Chapel Hill, NC); Jianping Sun (Belmont, CA); Eli S. Groban (San Francisco, CA)
Assignee: Intrexon Corporation
C12P7/16C12N9/0006C12N9/1022C12N9/1025C12N9/88C12N15/52C12Y101/01001C12Y101/01004C12Y202/01006C12Y203/03006C12Y401/01072C12Y402/01033C12Y403/01019
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,745,603
App. No.
15/192,290
Granted
Aug 29, 2017
Kind
B2
Abstract

Multi-carbon compounds such as ethanol, n-butanol, sec-butanol, isobutanol, tert-butanol, fatty (or aliphatic long chain) alcohols, fatty acid methyl esters, 2,3-butanediol and the like, are important industrial commodity chemicals with a variety of applications. The present invention provides metabolically engineered host microorganisms which metabolize methane (CH 4 ) as their sole carbon source to produce multi-carbon compounds for use in fuels (e.g., bio-fuel, bio-diesel) and bio-based chemicals. Furthermore, use of the metabolically engineered host microorganisms of the invention (which utilize methane as the sole carbon source) mitigate current industry practices and methods of producing multi-carbon compounds from petroleum or petroleum-derived feedstocks, and ameliorate much of the ongoing depletion of arable food source “farmland” currently being diverted to grow bio-fuel feedstocks, and as such, improve the environmental footprint of future bio-fuel, bio-diesel and bio-based chemical compositions.

Claims (12)

1. A genetically modified methanotroph that is capable of producing 2,3-butanediol from methane (CH 4 ), the genetically modified methanotroph comprising exogenous polynucleotides encoding acetolactate synthase and 2,3-butanediol dehydrogenase, wherein the acetolactate synthase has acetolactate synthase activity and comprises an amino acid sequence having at least 90% sequence homology to SEQ ID NO:2, and the 2,3-butanediol dehydrogenase has 2,3-butanediol dehydrogenase activity and comprises an amino acid sequence having at least 90% sequence homology to SEQ ID NO: 157, wherein said methanotroph is capable of converting methane to pyruvate through an endogenous type I RuMP pathway or a type II serine pathway.

2. The genetically modified methanotroph of claim 1 , wherein said methanotroph is Methylobacter, Methylomicrobium, Methylomonas, Methylocaldum, Methylococcus, Methylosoma, Methylosarcina, Methylothermus, Methylohalobius, Methylogaea, Methylovulum, Crenothrix, Clonothrix, Methylosphaera, Methylocapsa, Methylocella, Methylosinus, Methylocystis , or Methyloacidophilum.

3. The genetically modified microorganism of claim 2 , wherein said methanotroph is Methylococcus.

4. The genetically modified microorganism of claim 3 , wherein said Methylococcus is Methylococcus capsulatus.

5. A method of producing 2,3-butanediol from methane comprising:

(a) contacting a methanotroph with methane,

(b) growing said methanotroph under suitable growth conditions to produce said 2,3-butanediol,

wherein said methanotroph is capable of converting methane to pyruvate through an endogenous type I RuMP pathway or a type II serine pathway and comprises exogenous polynucleotides encoding acetolactate synthase and 2,3-butanediol dehydrogenase, wherein the acetolactate synthase has acetolactate synthase activity and comprises an amino acid sequence having at least 90% sequence homology to SEQ ID NO:2, and the 2,3-butanediol dehydrogenase has 2,3-butanediol dehydrogenase activity and comprises an amino acid sequence having at least 90% sequence homology to SEQ ID NO: 157.

6. The method of claim 5 , wherein said methanotroph is Methylobacter, Methylomicrobium, Methylomonas, Methylocaldum, Methylococcus, Methylosoma, Methylosarcina, Methylothermus, Methylohalobius, Methylogaea, Methylovulum, Crenothrix, Clonothrix, Methylosphaera, Methylocapsa, Methylocella, Methylosinus, Methylocystis , or Methyloacidophilum.

7. The method of claim 5 , further comprising isolating and purifying said 2,3-butanediol.

8. The method of claim 6 , wherein said methanotroph is Methylococcus.

9. The method of claim 8 , wherein said Methylococcus is Methylococcus capsulatus.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2025
From: PRECIGEN, INC.
To: BIOVERDE TECH LLC
Reel/Frame 072033/0001 →
CHANGE OF NAME Recorded Dec 7, 2020
From: INTREXON CORPORATION
To: PRECIGEN, INC.
Reel/Frame 054622/0455 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2017
From: COLEMAN, WILLIAM; VIDANES, GENEVIEVE; COTTAREL, GUILLAUME; MULEY, SHEELA; KAMIMURA, ROY; JAVAN, AKBAR; SUN, JIANPING; GROBAN, ELI
To: INTREXON CORPORATION
Reel/Frame 042287/0476 →
Continuity (4)
Division 14989859 · Jan 7, 2016
Division 14206835 · Mar 12, 2014
Provisional Application 61782830 · Mar 14, 2013
Related Publication 20170152529A1 · Jun 1, 2017